Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 10/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 10/20 | 0.60 |
| ▸ | MAPT | P10636 | 10/20 | 0.59 |
| ▸ | RAB9A | P51151 | 6/20 | 0.59 |
| ▸ | NPC1 | O15118 | 4/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.55 |
| ▸ | MT-CO2 | P00403 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | MTOR | P42345 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5460057 | 0.85 | P2RY1 (0.57) | MEN1KMT2AMAPTRAB9ANPC1 | |
| SCHEMBL5459931 | 0.84 | MEN1 (0.63) | MEN1KMT2AMAPTRAB9ANPC1 | |
| SCHEMBL5464818 | 0.83 | HTT (0.59) | MEN1KMT2AMAPTRAB9ANPC1 | |
| SCHEMBL5465662 | 0.82 | NPC1 (0.59) | MEN1KMT2AMAPTRAB9ANPC1 | |
| SCHEMBL5460707 | 0.82 | MT-CO2 (0.61) | MEN1KMT2AMAPTRAB9ANPC1 | |
| SCHEMBL5460083 | 0.82 | RAB9A (0.77) | MEN1KMT2AMAPTRAB9ANPC1 | |
| SCHEMBL5451277 | 0.80 | P2RY1 (0.55) | MEN1KMT2AMAPTRAB9ANPC1 | |
| SCHEMBL5455863 | 0.79 | KMT2A (0.62) | MEN1KMT2AMAPTRAB9ANPC1 | |
| SCHEMBL5458260 | 0.79 | NAMPT (0.61) | MEN1KMT2AMAPTRAB9ANPC1 | |
| SCHEMBL5453420 | 0.78 | P2RY1 (0.51) | MAPTRAB9ANPC1SMN1; SMN2P2RY1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070249620-A1 | Urea Derivative | SANKYO COMPANY, LIMITED (JP) | 2007-10-25 | — | — | US | disclosed |
| EP-1764360-A1 | UREA DERIVATIVE | Sankyo Company, Limited (JP) | 2007-03-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070249620-A1 | Urea Derivative | UGP2, SLC14A1, DGAT1 | MEN1 1828/4885KMT2A 1350/4885MAPT 758/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.